- Home
- PCVX vs CAG Comparison
PCVX vs CAG Comparison
Compare PCVX & CAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCVX | CAG |
|---|---|---|
| Founded | 2013 | 1919 |
| Country | United States | United States |
| Employees | N/A | 26100 |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 6.9B |
| IPO Year | 2020 | 1994 |
Fundamental Metrics
Financial Performance| Metric | PCVX | CAG |
|---|---|---|
| Price | $62.62 | $16.45 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 17 |
| Target Price | ★ $88.25 | $16.88 |
| AVG Volume (30 Days) | 908.4K | ★ 10.3M |
| Earning Date | 05-07-2026 | 04-01-2026 |
| Dividend Yield | N/A | ★ 9.84% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,500,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $29.87 | $12.53 |
| 52 Week High | $65.00 | $20.32 |
Technical Indicators
Market Signals| Indicator | PCVX | CAG |
|---|---|---|
| Relative Strength Index (RSI) | 63.30 | 69.73 |
| Support Level | $52.18 | $15.96 |
| Resistance Level | $65.00 | $17.83 |
| Average True Range (ATR) | 2.20 | 0.40 |
| MACD | 0.50 | 0.10 |
| Stochastic Oscillator | 90.12 | 94.41 |
Price Performance
Historical ComparisonAbout PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.
About CAG ConAgra Brands Inc.
Conagra Brands Inc is a packaged food company that operates predominantly in the United States (91% of fiscal 2025 revenue). The majority of its revenue comes from frozen food, including brands like Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Conagra also sells snacks, shelf-stable staples, and refrigerated food through brands like Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, and Wish-Bone. The company sells through the USA retail channel, with just 9% of fiscal 2025 revenue coming from international markets and 9% from foodservice.